Publications by authors named "B Jurigova"
Sensory processing dysfunction not only affects most individuals with autism spectrum disorder (ASD), but at least 5% of children without ASD also experience dysfunctional sensory processing. Our understanding of the relationship between sensory dysfunction and resting state brain activity is still emerging. This study compared long-range resting state functional connectivity of neural oscillatory behavior in children aged 8-12 years with autism spectrum disorder (ASD; N=18), those with sensory processing dysfunction (SPD; N=18) who do not meet ASD criteria, and typically developing control participants (TDC; N=24) using magnetoencephalography (MEG).
View Article and Find Full Text PDFInattention can negatively impact several aspects of a child's life, including at home and school. Cognitive and physical interventions are two promising non-pharmaceutical approaches used to enhance attention abilities, with combined approaches often being marketed to teachers, therapists, and parents typically without research validation. Here, we assessed the feasibility of incorporating an integrated, cognitive-physical, closed-loop video game (body-brain trainer or 'BBT') as an after-school program, and also evaluated if there were attention benefits following its use.
View Article and Find Full Text PDFArticle Synopsis
- The study aimed to evaluate the long-term effects of a cognitive training program (Project: EVO™) on children with Sensory Processing Dysfunction (SPD) over three years.
- Results indicated that children with SPD who also had Attention Deficit Hyperactivity Disorder (ADHD) showed significant and stable improvements in inattentive behaviors, maintained in a follow-up after nine months.
- By the end of the three-year period, 54% of the SPD+ADHD participants no longer met ADHD criteria, suggesting the digital health intervention may have lasting positive impacts on attention-related issues.
Objective: Atomoxetine has several characteristics that make it an attractive alternative to stimulants for treating ADHD, but there are currently no tests identifying individuals for whom the medication should be a first-line option.
Method: Within the ADHD Controlled Trial Investigation Of a Non-stimulant (ACTION) study, we examined neuro-cortical activity in 52 youth with ADHD. Baseline event-related potentials (ERP) were compared between those who subsequently responded to 6 weeks of atomoxetine versus those who did not.